A cross sectional study of Quality of Life in long-term adult survivors after allogeneic hematopoietic stem cell transplantatio
Not Applicable
- Conditions
- Hematopoietic stem cell trans- plantation targeted diseases such as hematological diseases
- Registration Number
- JPRN-UMIN000009545
- Lead Sponsor
- ate Effects / Quality of Life Working Group, the Japan Society for Hematopietic Cell Tranplantation
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up continuing
- Sex
- All
- Target Recruitment
- 300
Inclusion Criteria
Not provided
Exclusion Criteria
(1)Patients who disapproved of TRUMP search. (2)Patients who are disqualified by his attending physician.
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method We will examine QOL of adult survivors which assessed by SF-36, FACT-BMT and VAS described below. (1)SF-36: Compare QOL of patients with that of same sex, coeval national certified value. (2)FACT-BMT: Examine factors associated with QOL. (3)VAS: Compare VAS of patients and their attending physician and examine associated factors. (4)Factors which are associated with QOL *Donor and type of transplantation *Conditioning regimens and total body irradiation *Years after transplantation, reintegration into society, connubiality and restoration of gonadal function (5)Compare background factors of patients who are engaged in this study with who disapproved or unable to explain this study. (6)Compare patients who are included in this study and patients who are included in the pediatric study.
- Secondary Outcome Measures
Name Time Method